Related by context. All words. (Click for frequent words.) 75 DMARDs 74 TNF inhibitor 72 disease modifying antirheumatic 71 DMARD therapy 71 methotrexate 71 FOLFIRI 70 TNF inhibitors 70 adalimumab 70 XELOX 70 mycophenolate mofetil 69 infliximab 69 anti TNF 69 chlorambucil 69 methotrexate MTX 69 tocilizumab 69 CHOP chemotherapy 68 DMARDS 68 Doxil ® 68 FOLFOX4 68 imatinib 68 cytotoxic chemotherapy 68 antihypertensive therapy 68 methotrexate therapy 68 5-FU/LV 68 idarubicin 68 dacarbazine 68 metastatic RCC 68 teriparatide 68 biologic therapy 67 virological failure 67 zoledronic acid 67 vinorelbine 67 anti TNFs 67 temozolomide 67 APTIVUS r 67 azathioprine 67 carboplatin paclitaxel 67 peginterferon 67 bendamustine 67 ribavirin therapy 67 CANCIDAS 67 Fludara 66 FOLFOX 66 nilotinib 66 virologic failure 66 β blockers 66 decitabine 66 imatinib therapy 66 etanercept 66 eplerenone 66 metastatic renal cell carcinoma 66 dasatinib 66 tamsulosin 66 azacitidine 66 TNF alpha inhibitor 66 trabectedin 66 mitoxantrone 66 NRTIs 66 drug DMARD 66 daunorubicin 66 interferon alfa 66 preoperative chemotherapy 66 protease inhibitor PI 66 clodronate 66 raltegravir 66 rFVIIa 66 CIMZIA TM 66 monotherapy 66 pemetrexed 66 sunitinib 66 methotrexate monotherapy 66 uric acid lowering 66 intravenous bisphosphonates 66 irbesartan 66 TNF antagonist 65 rituximab 65 peginterferon alfa 2a 65 cytotoxic therapy 65 #mg dose [003] 65 Bevacizumab 65 trastuzumab 65 ibandronate 65 sorafenib Nexavar 65 5FU 65 salmeterol fluticasone 65 eptifibatide 65 vandetanib 65 dose dexamethasone 65 sulfasalazine 65 docetaxel chemotherapy 65 posaconazole 65 cabazitaxel 65 adriamycin 65 pCR 65 fluvastatin 65 tiotropium 65 clomipramine 65 lenalidomide dexamethasone 65 chemoradiotherapy 65 genotypic resistance 65 topotecan 65 alteplase 65 interferon alfa 2b 65 gemcitabine Gemzar 65 TACE 65 neoadjuvant therapy 65 paroxysmal AF 65 GnRH agonists 65 peginterferon alfa 65 heavily pretreated 65 calcineurin inhibitors 65 EBRT 65 docetaxel 65 ribavirin RBV 65 leucovorin 65 HSCT 65 bezafibrate 65 Gemcitabine 65 anthracycline taxane 64 FOLPI 64 abatacept 64 active comparator 64 Natalizumab 64 bevacizumab Avastin 64 angiotensin receptor blocker ARB 64 pregabalin 64 LHRH agonists 64 virologic response 64 DOXIL 64 DAPT 64 Lenalidomide 64 idraparinux 64 T2DM 64 prospectively defined 64 tolvaptan 64 xanthine oxidase inhibitor 64 alpha blocker 64 imatinib resistant 64 Taxotere ® 64 paclitaxel Taxol 64 placebo dexamethasone 64 FOLFIRINOX 64 certolizumab 64 pamidronate 64 Paraplatin ® 64 pegylated liposomal doxorubicin 64 anti leukemic 64 standard chemotherapy regimens 64 antiarrhythmic drug 64 androgen deprivation 64 CsA 64 glatiramer acetate 64 partial remissions 64 prednisone prednisolone 64 pegylated interferon alfa 64 angiotensin converting enzyme inhibitors 64 TMP SMX 64 concomitant medications 64 receptor tyrosine kinase inhibitor 64 bosentan 64 infusional 5-FU/LV 64 mTOR inhibitors 64 CCyR 64 neoadjuvant 64 pegylated interferon alpha 64 lacosamide 64 recurrent GBM 64 taxane chemotherapy 64 amphotericin B 64 interferon therapy 64 Dasatinib 64 pertuzumab 64 nadolol 64 non squamous NSCLC 64 AGILECT R 64 TNF antagonists 64 left ventricular dysfunction 64 FOLFOX6 64 neoadjuvant chemotherapy 64 VaD 64 TEAEs 64 tipranavir 64 peg IFN 64 diabetic gastroparesis 64 radiographic progression 64 ATACAND 64 chemotherapeutic regimens 64 overlapping toxicities 64 imipenem 64 gefitinib 64 triptan 64 fluconazole 64 INTELENCE 63 divalproex sodium 63 peginterferon alfa 2b 63 chemoradiation 63 gemcitabine 63 ELOXATIN 63 dosage regimens 63 antithrombotic 63 PegIFN RBV 63 adjuvant therapy 63 temsirolimus 63 hematologic toxicity 63 octreotide LAR 63 low dose cytarabine 63 serum urate 63 CIMZIA ™ 63 Herceptin trastuzumab 63 ACTEMRA TM 63 aspirin clopidogrel 63 ALT flares 63 thromboembolic events 63 oral antidiabetic 63 systemic corticosteroid 63 mCRC patients 63 hepatic metastases 63 aldosterone antagonists 63 Capecitabine 63 mRCC 63 flutamide 63 macroalbuminuria 63 immunomodulatory therapy 63 paricalcitol 63 lipid lowering therapies 63 gefitinib Iressa 63 heavily pretreated patients 63 fludarabine 63 olmesartan 63 interferon ribavirin 63 chemotherapeutic regimen 63 antithrombotic therapy 63 lamivudine 63 capecitabine 63 Hycamtin ® 63 Erlotinib 63 plus methotrexate 63 dose cytarabine 63 Peg IFN 63 cetuximab 63 abciximab 63 levosimendan 63 erlotinib 63 docetaxel Taxotere 63 teriflunomide 63 sustained virologic response 63 esomeprazole 63 Helicobacter pylori eradication 63 relapsed MM 63 remission induction 63 VAPRISOL 63 TAXOTERE R 63 irinotecan 63 HER2 overexpression 63 Candesartan 63 antiandrogen 63 iniparib 63 AZT zidovudine Retrovir 63 alendronate 63 alkylating agent 63 ABC/3TC 63 maximal doses 63 amoxicillin clavulanate 63 PsA 63 standard chemotherapy regimen 63 relapsed SCLC 63 Mylotarg 63 cytogenetic response 63 rasagiline 63 tumor shrinkage 63 caspofungin 63 mg BID 63 intravenous cyclophosphamide 63 bexarotene 63 conventional DMARDs 63 nephrotoxicity 63 rhGH 63 docetaxel Taxotere ® 63 nab paclitaxel 63 ritonavir boosted 63 IFN beta 63 KRAS mutations occur 63 4mg/kg 63 allopurinol 63 TDF FTC 63 nonresponders 63 NRTI 63 angiotensin converting enzyme inhibitor 63 ritonavir boosted protease inhibitor 63 lenalidomide Revlimid R 63 hypercalcemia 63 anti rheumatic 63 neostigmine 63 abacavir lamivudine 63 dalteparin 62 leukemia AML 62 ULORIC 62 anastrozole 62 bortezomib 62 ARIMIDEX 62 QTc prolongation 62 ZOLINZA 62 Taxol paclitaxel 62 DFMO 62 lipid lowering drugs 62 enalapril 62 triamcinolone 62 tenofovir emtricitabine 62 anthracycline containing 62 corticosteroid therapy 62 HBeAg positive patients 62 achieved ACR# 62 boosted protease inhibitor 62 Monotherapy 62 adalimumab Humira 62 leflunomide 62 baminercept 62 XGEVA 62 cytostatic 62 Pegasys ® 62 lipid lowering agents 62 IFN α 62 ACTEMRA 62 Gemzar ® 62 sotalol 62 doxazosin 62 LHRH agonist 62 atazanavir ritonavir 62 OADs 62 bicalutamide 62 sustained virological response 62 bevacizumab 62 elotuzumab 62 chemotherapy regimens 62 melphalan prednisone 62 ethambutol 62 chemotherapy regimen 62 haematologic 62 prior chemotherapy regimens 62 immunosuppressive agents 62 interferon beta therapy 62 T#I [002] 62 biologic DMARD 62 adjuvant chemotherapy 62 relapsing remitting 62 Pemetrexed 62 fibrinolytic 62 adverse cytogenetics 62 TNF alpha inhibitors 62 ziprasidone 62 Betaferon ® 62 imatinib Gleevec 62 Bortezomib 62 glargine 62 chemoradiation therapy 62 Elitek 62 entecavir 62 adefovir 62 goserelin 62 enfuvirtide 62 bevacizumab Avastin ® 62 relapsed ovarian cancer 62 recurrent glioblastoma multiforme 62 pegylated 62 oxaliplatin 62 Combination therapy 62 EGFR inhibitors 62 CTEPH 62 Protelos 62 pegylated interferon alfa 2b 62 doxorubicin docetaxel 62 ZYVOX 62 mapatumumab 62 pneumonectomy 62 pegfilgrastim 62 fondaparinux 62 lipid lowering therapy 62 Adjuvant chemotherapy 62 stavudine d4T 62 carvedilol 62 Traficet EN 62 PREZISTA r 62 interferon IFN 62 interferon alfa 2a 62 pegylated interferon 62 chemotherapy docetaxel 62 Sutent sunitinib 62 Adalimumab 62 Etanercept 62 Rituximab 62 GnRH agonist 62 galiximab 62 thalidomide Thalomid 62 lupus nephritis 62 MYLOTARG 62 erlotinib Tarceva ® 62 antiepileptic drugs AEDs 62 cisplatin chemotherapy 62 Cloretazine 62 RoACTEMRA 62 zolmitriptan 62 disease modifying 62 beta blocker therapy 62 endothelin receptor antagonists 62 ketoconazole 62 antithrombotics 62 eribulin 62 thiazide diuretic 62 myelosuppression 62 efalizumab 62 complete cytogenetic response 62 Hazard Ratio 62 epirubicin 62 crizotinib PF # 62 FASLODEX 62 Atacand 62 plus ribavirin 62 pomalidomide 62 immunosuppressive regimen 62 cytarabine 62 antimuscarinic 62 metastatic malignant 62 complete remissions 62 oral antidiabetes drugs 62 fluorouracil 62 ISENTRESS 62 insulin detemir 62 paclitaxel carboplatin 62 tipranavir ritonavir 62 sunitinib malate 62 cinacalcet 62 d4T 62 immunosuppressant 62 Ramipril 62 mg kg dose 62 paclitaxel eluting stents 62 oral diclofenac 62 sorafenib 62 pegylated liposomal doxorubicin PLD 62 Torisel 62 glucocorticoids 62 tyrosine kinase inhibitors 62 3TC lamivudine Epivir 62 response CCyR 62 APTIVUS 62 dexamethasone 62 TNF antagonist therapies 62 anthracycline 62 Pegylated Liposomal Doxorubicin 61 Amrubicin 61 comparator arm 61 candesartan 61 nonrandomized 61 postoperative chemotherapy 61 trastuzumab Herceptin ® 61 serum HBV DNA 61 erlotinib Tarceva 61 NNRTI 61 anti TNF alpha 61 citalopram 61 TORISEL 61 TNF blocker therapy 61 Velcade bortezomib 61 Taxotere R 61 candesartan cilexetil 61 pramipexole 61 virological response 61 metastatic HRPC 61 oxcarbazepine 61 desvenlafaxine succinate 61 fluoropyrimidine 61 COPAXONE R 61 mirtazapine 61 darunavir ritonavir 61 interferon beta 1a 61 dasatinib Sprycel ® 61 tirofiban 61 CIMZIA TM certolizumab pegol 61 antiretroviral regimen 61 hypogonadal men 61 cetuximab Erbitux ® 61 metformin monotherapy 61 hormonal therapies 61 PegIntron 61 Gefitinib 61 fulvestrant 61 Hycamtin 61 ACZ# 61 transaminase elevations 61 long acting bronchodilator 61 nucleoside analogues 61 canakinumab 61 vismodegib 61 imatinib mesylate 61 efavirenz EFV 61 ARCOXIA 61 drugs DMARDs 61 receiving VICTRELIS 61 Methotrexate 61 thiazolidinedione 61 Targretin 61 nelfinavir 61 AZILECT 61 plus dexamethasone 61 doxorubicin HCl liposome injection 61 surrogate endpoint 61 irinotecan chemotherapy 61 SJIA 61 SCCHN 61 tamoxifen therapy 61 liposomal doxorubicin 61 inotropic 61 metformin sulfonylurea 61 SELZENTRY 61 lispro 61 sertraline 61 narcotic analgesics 61 advanced NSCLC 61 antihypertensive drugs 61 pioglitazone 61 unfractionated heparin 61 AA Amyloidosis 61 oral rivaroxaban 61 RLAI 61 anakinra 61 Filgrastim 61 gemcitabine carboplatin 61 potentially hepatotoxic 61 benazepril 61 trimethoprim sulfamethoxazole 61 coronary revascularization 61 venlafaxine Effexor 61 linezolid 61 KAPIDEX 61 relapsing MS 61 zonisamide SR 61 selegiline 61 Irinotecan 61 EDSS score 61 severe neutropenia 61 Xanafide 61 gemifloxacin 61 TYKERB 61 antiplatelet agent 61 patients evaluable 61 ß blockers 61 bosutinib 61 ivabradine 61 FAMPYRA 61 fibrinolytic therapy 61 riociguat 61 antiepileptics 61 stage IIIB 61 hypomethylating agents 61 antidiabetic drugs 61 carbidopa levodopa 61 antihypertensive agents 61 dacarbazine chemotherapy 61 leukotriene receptor antagonist 61 seropositive patients 61 VELCADE melphalan 61 renal dysfunction 61 pharmacotherapies 61 tigecycline 61 immunosuppressant therapy 61 polyarticular 61 piperacillin tazobactam 61 antihypertensives 61 cetuximab Erbitux R 61 oxycodone CR 61 corticosteroid 61 strontium ranelate 61 SLNB 61 neurologic progression 61 FIRMAGON 61 briakinumab 61 ONGLYZA ™ 61 RRMS patients 61 indolent NHL 61 complete cytogenetic 61 unresectable 61 glulisine 61 anthracycline therapy 61 serum HCV RNA 61 dacarbazine DTIC 61 superficial bladder cancer 61 eosinophilic asthma 61 Pioglitazone 61 biochemical recurrence 61 Flu Cy 61 gliclazide 61 metastatic CRC 61 acute GvHD 61 cardiac toxicity 61 rosuvastatin Crestor 61 lymphadenectomy 61 beta interferon 61 Diovan HCT 61 ixabepilone 61 bisphosphonate therapy 61 Interferon alfa 61 doxorubicin 61 refractory AML 61 aripiprazole 61 lamotrigine 61 glucose lowering 61 reperfusion therapy 61 levodopa therapy 61 COPAXONE ® 61 thrombolytic agents 61 antiarrhythmic drugs 61 valsartan 61 estramustine 61 cytopenias 61 intravitreal injections 61 pyrazinamide 61 pentoxifylline 61 sulphonylurea 61 mitoxantrone chemotherapy 61 BEACOPP 60 micafungin 60 tumor necrosis 60 ARB telmisartan 60 alefacept 60 null responders 60 cyclophosphamide 60 quetiapine 60 trans retinoic acid 60 relapsing multiple sclerosis 60 BRAF inhibitor 60 nortriptyline 60 TEMODAL 60 refractory CTCL 60 dacetuzumab 60 liver metastasis 60 timepoints 60 darunavir r 60 aromatase inhibitor 60 cisplatin 60 HRPC 60 gastrointestinal stromal tumor GIST 60 NNRTIs 60 quinolone 60 itraconazole 60 dexamethasone Decadron 60 TELCYTA 60 CAELYX 60 hypercholesterolemia 60 colorectal liver metastases 60 thromboprophylaxis 60 nonadherence 60 reinfarction 60 Vfend 60 nucleoside analogs 60 acute gout flares 60 Ranolazine 60 external beam radiotherapy 60 saline placebo 60 locoregional 60 bone metastases 60 risedronate 60 calcineurin inhibitor 60 Fulvestrant 60 sulphonylureas 60 intravenous dosing 60 HBeAg negative 60 CR nPR 60 REMICADE ® 60 pazopanib 60 CYP #A# 60 HMG CoA reductase inhibitor 60 hydroxychloroquine 60 Quetiapine 60 achieve sustained virologic 60 urate lowering therapy 60 Aptivus ® 60 eribulin mesylate 60 Platinol 60 refractory NSCLC 60 gout flares 60 cystectomy 60 DOXIL ® 60 isoproterenol 60 definite stent thrombosis 60 Oral corticosteroids 60 resectable 60 amrubicin 60 ceftazidime 60 nicardipine 60 PEGINTRON TM 60 Navelbine 60 EGFR TKI 60 morphometric vertebral fractures 60 adjuvant radiation 60 NNRTI resistance 60 metformin 60 VA# [002] 60 CA4P 60 #mg/day [002] 60 typical antipsychotics 60 fallopian tube cancers 60 CRp 60 venlafaxine 60 locoregional recurrence 60 atazanavir 60 hepatotoxicity 60 glyburide 60 zalutumumab 60 biologic DMARDs 60 darunavir 60 paroxetine Paxil 60 carboplatin 60 Pharmacokinetics PK 60 atorvastatin #mg 60 taxanes 60 INC# 60 Trastuzumab 60 mcg dose 60 TKI therapy 60 Tarceva erlotinib 60 tapentadol ER 60 cranial irradiation 60 splenectomized patients 60 achieved statistical significance 60 clopidogrel Plavix 60 ORENCIA ® 60 iodixanol 60 paliperidone palmitate 60 oral antidiabetes 60 oxaliplatin Eloxatin 60 HAART regimen 60 rizatriptan 60 erythropoietic 60 sorafenib Nexavar ® 60 PEG IFN 60 peritumoral brain edema 60 Femara letrozole 60 Lamotrigine 60 salmeterol HFA MDI 60 antithymocyte globulin 60 Decitabine 60 MIRAPEX 60 beta blocker 60 pimecrolimus 60 tolterodine ER 60 tumor lysis syndrome 60 epoetin alfa 60 MGd 60 fluticasone propionate 60 haloperidol Haldol 60 clopidogrel 60 pegylated interferons 60 #mg dose [001] 60 platinum refractory 60 terazosin 60 thienopyridine 60 voriconazole 60 chronic lymphocytic leukemia CLL 60 infliximab therapy 60 mesalamine granules 60 fluticasone salmeterol 60 noninferior 60 subcutaneously administered 60 viral kinetics 60 calcitriol 60 #mg/m# [001] 60 infusional 60 visilizumab 60 Cimzia ® 60 azacytidine 60 ertapenem 60 LHRH analogues 60 neuroleptic 60 desvenlafaxine 60 peg interferon 60 antiandrogens 60 lanreotide 60 fosamprenavir 60 cilostazol 60 nonoperative treatment 60 pharmacokinetic interactions 60 mycophenolic acid 60 8mg/kg 60 apremilast 60 montelukast 60 SCIg 60 androgen suppression 60 ketorolac 60 Celecoxib 60 metastatic GIST 60 risperidone Risperdal 60 platelet inhibitor 60 neuroleptics 60 chlorthalidone 60 bone metastasis 60 brain metastases 60 NOXAFIL 60 Epivir 60 Ph + ALL 60 cholinesterase inhibitor 60 Doxil 60 Darunavir 60 imatinib Gleevec ® 60 NPH insulin 60 MICARDIS ® 60 Cisplatin 60 neoadjuvant treatment 60 biliary tract cancer 60 hormonal therapy 60 reboxetine 60 concurrent chemoradiation 60 systemic corticosteroids 60 Bezielle 60 celecoxib 60 EGFR tyrosine kinase inhibitors 60 FluCAM 60 alfa 2a 60 captopril 60 ASCT 60 NYHA class 60 β blocker 60 FROVA 60 disease progression 60 sertraline Zoloft 60 Mitoxantrone 60 LEXIVA r 60 oral antidiabetic drugs 60 MYCAMINE 60 radioiodine therapy 60 ddI 60 FOLFIRI alone 60 d4T stavudine Zerit 60 cytarabine daunorubicin 60 cangrelor 60 warfarin therapy 60 antiemetic 60 YONDELIS 60 ACE Inhibitors 60 etanercept Enbrel 60 amiodarone 60 imiquimod 60 Avastin bevacizumab 60 platelet inhibition 60 rituximab Rituxan 60 pyridostigmine 60 timolol 60 Dapagliflozin 60 nonmetastatic prostate cancer 60 TRIZIVIR 60 moderate renal impairment 60 immunosuppressive therapies 60 relapsers 60 panitumumab Vectibix 60 HER2 positive metastatic breast 60 NSCLC 60 untreated multiple myeloma 60 epithelial tumors 60 dexrazoxane 60 Ziprasidone 60 rheumatoid arthritis RA 60 IOP lowering 60 Primary endpoints 60 Cytoxan 60 Folfox 60 tenofovir DF 59 PNH patients 59 odanacatib 59 ALGRX 59 renal toxicity 59 Corticosteroids 59 antidiabetic 59 oral antidiabetic agents 59 anticholinergics 59 trials RCTs 59 LVEF 59 tacrolimus ointment 59 somatostatin analogs 59 Jevtana 59 acarbose 59 hemorrhagic complications 59 Triapine R 59 anthracyclines 59 #mg/day [001] 59 temsirolimus Torisel ® 59 vertebral fracture 59 Imatinib 59 Bosentan 59 Aclasta 59 advanced adenomas 59 Carboplatin 59 adjuvant therapies 59 metastatic malignant melanoma 59 TURP 59 BARACLUDE ® 59 glitazones 59 CYP#C# [001] 59 SERCA2a 59 achieved sustained virological 59 dose clopidogrel 59 tranylcypromine 59 DAS# remission 59 HBeAg negative patients 59 tricyclic antidepressant 59 chemotherapeutic drug 59 pioglitazone Actos 59 cytotoxic agents 59 nucleoside analogue 59 tibolone 59 dasatinib Sprycel 59 Doxorubicin 59 Sandostatin LAR 59 degarelix 59 infliximab Remicade 59 amisulpride 59 Epirubicin 59 N acetylcysteine 59 follicular lymphoma FL 59 plus prednisone 59 aromatase inhibitor therapy 59 etoposide 59 TKIs 59 ACR# response 59 aflibercept 59 NSAID 59 oral FTY# 59 androgen therapy 59 fenofibrate 59 anxiolytic 59 cidofovir 59 detectable HCV RNA 59 glitazone 59 virologic breakthrough 59 preserved ejection fraction 59 tumor recurrence 59 colorectal adenoma 59 MAOI 59 Neulasta ® 59 generalized tonic clonic seizures 59 Q#IR 59 interferon 59 Visipaque 59 gemcitabine chemotherapy 59 scintigraphic 59 relapsed MCL 59 nonvertebral fracture 59 exemestane 59 LMWH 59 tricyclic antidepressants 59 romiplostim 59 gastrointestinal stromal tumors GIST 59 paliperidone ER 59 EDSS scores 59 Sorafenib 59 bupropion SR 59 interferon gamma 1b 59 bisphosphonate 59 KRAS mutant tumors 59 INVEGA ® 59 antiplatelet therapy 59 TNFα 59 Noxafil 59 Nilotinib 59 TNF therapy 59 bortezomib Velcade 59 primidone 59 angiotensin converting enzyme ACE 59 nucleoside reverse transcriptase inhibitor 59 dose titration 59 Navelbine ® 59 febuxostat 59 fluvoxamine 59 solifenacin 59 epoetin beta 59 diastolic heart 59 oral bisphosphonates 59 losartan 59 PREZISTA rtv 59 invasive candidiasis 59 Tamibarotene 59 myocardial ischemia 59 PROMACTA 59 LPV r 59 PEGINTRON 59 doxorubicin cyclophosphamide 59 Telintra 59 weekly subcutaneous injections 59 PEG Intron 59 clozapine 59 Peginterferon 59 relapsing remitting multiple sclerosis 59 serum creatinine levels 59 oral Xeloda 59 fluoxetine Prozac 59 LEXIVA 59 conventional antipsychotics 59 epoetin 59 luteinizing hormone releasing 59 rHuPH# 59 palifermin